NutriBand Inc. cotiza a 5.85 USD y tiene una capitalización bursátil de $71M. En los últimos 12 meses ha facturado $2M con un margen de flujo de caja libre del -252.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinic…
| Periodo | 2026-04 | 2025-12 | 2025-09 | 2025-05 |
|---|---|---|---|---|
| Real | $-0.04 | $-0.32 | $-2.12 | $-0.12 |
| Estimado | $-1.89 | $-2.13 | $-0.17 | $-0.16 |
| Sorpresa | +97.9% | +85.0% | -1147.1% | +25.0% |
| Métrica | NTRB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 27.8% | 57.0% | -29.2% |
| Operating Margin | -408.4% | -38.6% | -369.8% |
| Net Margin | -404.1% | -33.6% | -370.5% |
| FCF Margin | -252.4% | -13.9% | -238.5% |
| ROE | -123.2% | -40.4% | -82.8% |
| ROA | -109.0% | -32.0% | -77.0% |
| Current Ratio | 6.36 | 2.84 | +3.52 |
| Debt / Equity | 0.01 | 0.28 | -0.27 |